Evidence map›Paper›PMID 35674565›Full record

ArticleRevista da Sociedade Brasileira de Medicina Tropical2022

How to overcome the stagnation of the first dose vaccine coverage curve against coronavirus disease 2019 in Brazil?

Raphael Mendonça Guimarães, Diego Ricardo Xavier, Raphael de Freitas Saldanha, Mônica de Avelar Figueiredo Mafra Magalhães

Abstract read
In one paragraph

Article in Revista da Sociedade Brasileira de Medicina Tropical, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Raphael Mendonça GuimarãesFundação Oswaldo Cruz, Escola Nacional de Saúde Pública, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0003-1225-6719
Diego Ricardo XavierFundação Oswaldo Cruz, Instituto de Comunicação e Informação em Ciência e Tecnologia, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0001-5259-7732
Raphael de Freitas SaldanhaFundação Oswaldo Cruz, Instituto de Comunicação e Informação em Ciência e Tecnologia, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0003-0652-8466
Mônica de Avelar Figueiredo Mafra MagalhãesFundação Oswaldo Cruz, Instituto de Comunicação e Informação em Ciência e Tecnologia, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0002-6595-8274

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA large percentage of the population has not yet started vaccination, for which the increase in coverage is almost null.

methodsWe used segmented regression analysis to estimate trends in the first dose coverage curve.

resultsThere has been a slowdown in the application of the first doses in Brazil since epidemiological week 36 (average percent change [APC] 0.83%, 95% confidence interval [CI] 0.75-0.91%), with a trend close to stagnation.

conclusionsIt is important to develop strategies to increase access to vaccination posts. Furthermore, it is recommended to expand vaccination to children, thereby increasing the eligible population.

Indexed as

COVID-19VaccinesBrazilChildHumansVaccinationVaccines

Identifiers

PMID35674565
PMCPMC9176729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.